220 related articles for article (PubMed ID: 31377472)
1. Polymer-based nanoparticles for chemo/gene-therapy: Evaluation its therapeutic efficacy and toxicity against colorectal carcinoma.
Chen Y; Li N; Xu B; Wu M; Yan X; Zhong L; Cai H; Wang T; Wang Q; Long F; Jiang G; Xiao H
Biomed Pharmacother; 2019 Oct; 118():109257. PubMed ID: 31377472
[TBL] [Abstract][Full Text] [Related]
2. Polymeric Nanomedicine for Combined Gene/Chemotherapy Elicits Enhanced Tumor Suppression.
Xu B; Xia S; Wang F; Jin Q; Yu T; He L; Chen Y; Liu Y; Li S; Tan X; Ren K; Yao S; Zeng J; Song X
Mol Pharm; 2016 Feb; 13(2):663-76. PubMed ID: 26695934
[TBL] [Abstract][Full Text] [Related]
3. Pigment epithelial-derived factor gene loaded novel COOH-PEG-PLGA-COOH nanoparticles promoted tumor suppression by systemic administration.
Yu T; Xu B; He L; Xia S; Chen Y; Zeng J; Liu Y; Li S; Tan X; Ren K; Yao S; Song X
Int J Nanomedicine; 2016; 11():743-59. PubMed ID: 26955272
[TBL] [Abstract][Full Text] [Related]
4. Pigment epithelium-derived factor gene loaded in cRGD-PEG-PEI suppresses colorectal cancer growth by targeting endothelial cells.
Li L; Yang J; Wang WW; Yao YC; Fang SH; Dai ZY; Hong HH; Yang X; Shuai XT; Gao GQ
Int J Pharm; 2012 Nov; 438(1-2):1-10. PubMed ID: 22974524
[TBL] [Abstract][Full Text] [Related]
5. Co-delivery of sorafenib and crizotinib encapsulated with polymeric nanoparticles for the treatment of
Zhong T; Liu X; Li H; Zhang J
Drug Deliv; 2021 Dec; 28(1):2108-2118. PubMed ID: 34607478
[TBL] [Abstract][Full Text] [Related]
6. Decreasing acute toxicity and suppressing colorectal carcinoma using Sorafenib-loaded nanoparticles.
Li N; Chen Y; Sun H; Huang T; Chen T; Jiang Y; Yang Q; Yan X; Wu M
Pharm Dev Technol; 2020 Jun; 25(5):556-565. PubMed ID: 31958240
[No Abstract] [Full Text] [Related]
7. The pigment epithelial-derived factor gene loaded in PLGA nanoparticles for therapy of colon carcinoma.
Cui FY; Song XR; Li ZY; Li SZ; Mu B; Mao YQ; Wei YQ; Yang L
Oncol Rep; 2010 Sep; 24(3):661-8. PubMed ID: 20664971
[TBL] [Abstract][Full Text] [Related]
8. Sorafenib and Piperine co-loaded PLGA nanoparticles: Development, characterization, and anti-cancer activity against hepatocellular carcinoma cell line.
Alhudaithi SS; Abul Kalam M; Binobaid L; Ali R; Almutairi MM; Qamar W; Bin Hithlayn H; Almutairi A; Alshememry AK
Saudi Pharm J; 2024 May; 32(5):102064. PubMed ID: 38633710
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of parthenolide nanocrystals for enhancing therapeutic effects of sorafenib against advanced hepatocellular carcinoma.
Liang P; Wu H; Zhang Z; Jiang S; Lv H
Int J Pharm; 2020 Jun; 583():119375. PubMed ID: 32344021
[TBL] [Abstract][Full Text] [Related]
10. Co-delivery of sorafenib and metapristone encapsulated by CXCR4-targeted PLGA-PEG nanoparticles overcomes hepatocellular carcinoma resistance to sorafenib.
Zheng N; Liu W; Li B; Nie H; Liu J; Cheng Y; Wang J; Dong H; Jia L
J Exp Clin Cancer Res; 2019 May; 38(1):232. PubMed ID: 31151472
[TBL] [Abstract][Full Text] [Related]
11. Cancer-targeted PEDF-DNA therapy for metastatic colorectal cancer.
Bao X; Zeng J; Huang H; Ma C; Wang L; Wang F; Liao X; Song X
Int J Pharm; 2020 Feb; 576():118999. PubMed ID: 31893541
[TBL] [Abstract][Full Text] [Related]
12. Combined Tumor- and Neovascular-"Dual Targeting" Gene/Chemo-Therapy Suppresses Tumor Growth and Angiogenesis.
Xu B; Jin Q; Zeng J; Yu T; Chen Y; Li S; Gong D; He L; Tan X; Yang L; He G; Wu J; Song X
ACS Appl Mater Interfaces; 2016 Oct; 8(39):25753-25769. PubMed ID: 27615739
[TBL] [Abstract][Full Text] [Related]
13. Photoreceptor rescue of pigment epithelium-derived factor-impregnated nanoparticles in Royal College of Surgeons rats.
Akiyama G; Sakai T; Kuno N; Kimura E; Okano K; Kohno H; Tsuneoka H
Mol Vis; 2012; 18():3079-86. PubMed ID: 23304068
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory effects of a synthetic peptide derived from pigment epithelium-derived factor on H₂O₂-induced corneal injury in vitro.
Lu Y; Feng J; Yang L; Tang H; Jin J; Xu X
Chin Med J (Engl); 2014; 127(8):1438-44. PubMed ID: 24762585
[TBL] [Abstract][Full Text] [Related]
15. Combination of pigment epithelium-derived factor with radiotherapy enhances the antitumor effects on nasopharyngeal carcinoma by downregulating vascular endothelial growth factor expression and angiogenesis.
Xu Z; Fang S; Zuo Y; Zhang Y; Cheng R; Wang Q; Yang Z; Cai W; Ma J; Yang X; Gao G
Cancer Sci; 2011 Oct; 102(10):1789-98. PubMed ID: 21707863
[TBL] [Abstract][Full Text] [Related]
16. pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities.
Zhang J; Li J; Shi Z; Yang Y; Xie X; Lee SM; Wang Y; Leong KW; Chen M
Acta Biomater; 2017 Aug; 58():349-364. PubMed ID: 28455219
[TBL] [Abstract][Full Text] [Related]
17. Pigment Epithelium-Derived Factor-Loaded PEGylated Nanoparticles as a New Antiangiogenic Therapy for Neovascularization.
Zhao F; Fei W; Li Z; Yu H; Xi L
J Diabetes Res; 2022; 2022():1193760. PubMed ID: 35493608
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacy of sorafenib and plant-derived phytochemicals in human colorectal cancer cells.
Bahman A; Abaza MS; Khoushaish S; Al-Attiyah RJ
BMC Complement Med Ther; 2023 Jun; 23(1):210. PubMed ID: 37365571
[TBL] [Abstract][Full Text] [Related]
19. Improved anti-colorectal carcinomatosis effect of tannic acid co-loaded with oxaliplatin in nanoparticles encapsulated in thermosensitive hydrogel.
Ren Y; Li X; Han B; Zhao N; Mu M; Wang C; Du Y; Wang Y; Tong A; Liu Y; Zhou L; You C; Guo G
Eur J Pharm Sci; 2019 Feb; 128():279-289. PubMed ID: 30553061
[TBL] [Abstract][Full Text] [Related]
20. Indocyanine green/doxorubicin-encapsulated functionalized nanoparticles for effective combination therapy against human MDR breast cancer.
Chen HH; Lu IL; Liu TI; Tsai YC; Chiang WH; Lin SC; Chiu HC
Colloids Surf B Biointerfaces; 2019 May; 177():294-305. PubMed ID: 30771581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
